Aurinia Pharmaceuticals Financial Overview
Aurinia Pharmaceuticals's market cap is currently $2.06B. The company's EPS TTM is $0.23; its P/E ratio is 27.95; Aurinia Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.
